查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1279846

2023-2030年全球抗酸劑市場規模研究與預測，按配方類型（片劑、粉劑、其他）、配銷通路（醫院藥店、電子商務、其他）和區域分析

Global Antacids Market Size study & Forecast, by Formulation Type (Tablet, Powder, Others) By Distribution Channel (Hospital Pharmacies, E-Commerce, Others) and Regional Analysis, 2023-2030
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3個工作天內

價格

抗酸劑是一種幫助減少胃酸和緩解胃酸過多相關症狀的藥物。這些非處方藥的有效成分是碳酸氫鈉、鈣、鎂或鋁。它們的作用是與胃酸結合，產生中性化學物質，可以降低胃內容物的酸度。因此，抗酸劑可用於治療包括消化不良、胃灼熱和胃酸倒流等癥狀。抗酸劑經常用於治療胃酸過多引起的癥狀。它們有助於平衡促使胸部或胃部灼熱的酸。推動市場增長的關鍵因素是胃酸逆流和胃食道逆流的流行率上升，OTC抗酸劑的容易獲得以及老年人口對抗酸劑的需求增加，預計將在預測期內支援市場增長。

此外，老年人口的增加是促進抗酸劑市場增長的因素之一。隨著年齡的增長，他們更容易出現胃腸道問題，如胃酸逆流、胃灼熱和胃食道逆流病（GERD）。這些情況會引起胸部和喉嚨的不適和疼痛，還可能促使其他健康並發症。因此，老年人口的增加預計將支持市場的增長。根據世界銀行的數據，2015年，印度65歲及以上的人口數量為7461萬，2021年該數位達到9575萬。另外，根據同一來源，2016年，義大利65歲及以上人口占總人口的22%，2021年這一數位將達到24%。因此，該地區不斷增長的老年人口預計將為市場創造一個有利可圖的需求。此外，全球人口迅速變化的生活方式預計將在預測期內為市場創造有利可圖的機會。然而，在2023-2030年的預測期內，抗酸劑市場上越來越多的替代品可能會扼殺市場增長。

全球抗酸劑市場研究涵蓋的主要地區包括亞太、北美、歐洲、拉美、中東和非洲。北美在2022年主導了市場，因為該地區有主要的市場參與者，有發達的醫療基礎設施，胃灼熱病例的增加，以及容易獲得非處方藥。在預測期內，亞太地區預計將大幅增長，因為諸如老年人口的增加、製藥公司的增加、醫療開支的增加和人們對胃灼熱認識的提高等因素預計將推動市場增長。

該研究的目的是定義近年來不同市場區隔和國家的市場規模，並預測未來幾年的價值。該報告旨在涵蓋參與研究的國家/地區的該行業的定性和定量方面。

該報告還提供了關於關鍵方面的詳細資訊，如驅動因素和挑戰，這將確定市場的未來增長。此外，它還涵蓋了微觀市場的潛在機會，供利益相關者投資，並詳細分析了競爭格局和主要參與者的產品。 .

目錄

第一章：執行摘要

  • 市場簡介
  • 2020-2030年全球和細分市場的估計和預測
    • 2020-2030年抗酸劑市場，按地區分類
    • 2020-2030年，抗酸劑市場，按配方類型分類
    • 2020-2030年抗酸劑市場，按配銷通路分類
  • 主要趨勢
  • 估算方法
  • 研究假設

第二章：全球抗酸劑市場的定義和範圍

  • 本研究的目的
  • 市場定義和範圍
    • 行業演變
    • 研究的範圍
  • 研究涵蓋的年份
  • 貨幣兌換率

第三章：全球抗酸劑市場動態

  • 抗酸劑市場影響分析（2020-2030年）
    • 市場驅動力
      • 胃酸倒流和胃食道逆流病的發病率上升
      • 易於獲得OTC抗酸劑
      • 老年人群對抗酸劑的需求上升
    • 市場挑戰
      • 替代品的可用性
    • 市場機會
      • 全球人口快速變化的生活方式

第四章：全球抗酸劑市場行業分析

  • 波特的5力模型
    • 供應商的議價能力
    • 買方的議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭性的競爭
  • 波特五力影響分析
  • PEST分析
    • 政治
    • 經濟
    • 社會
    • 技術
    • 環境
    • 法律問題
  • 最佳投資機會
  • 最佳策略
  • COVID-19影響分析
  • 顛覆性趨勢
  • 行業專家的觀點
  • 分析師建議和結論

第五章：全球抗酸劑市場，按配方類型分類

  • 市場簡介
  • 按配方類型分類的全球抗酸劑市場，性能-潛力分析
  • 2020-2030年全球抗酸劑市場按配方類型的估計和預測
  • 抗酸劑市場，細項分析
    • 片劑
    • 粉劑
    • 其他類型

第六章：全球抗酸劑市場，按配銷通路分類

  • 市場簡介
  • 按配銷通路分類的全球抗酸劑市場，表現- 潛力分析
  • 2020-2030年全球抗酸劑市場按配銷通路的估計和預測
  • 抗酸劑市場，次級細項分析
    • 醫院藥店
    • 電子商務
    • 其他市場

第7章：全球抗酸劑市場，區域分析

  • 最領先的國家
  • 新興國家
  • 抗酸劑市場，區域市場簡介
  • 北美洲
    • 美國
      • 2020-2030年配方類型的細分估計和預測
      • 2020-2030年，配銷通路的細分估計和預測
    • 加拿大
  • 歐洲抗酸劑市場概況
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 亞太地區抗酸劑市場簡介
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 韓國
    • 亞太其他地區
  • 拉丁美洲抗酸劑市場簡介
    • 巴西
    • 墨西哥
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 中東和非洲其他地區

第八章：競爭情報

  • 主要公司SWOT分析
    • 公司1
    • 公司二
    • 公司3
  • 頂級市場戰略
  • 公司簡介
    • Abbott Laboratories
      • 關鍵資訊
      • 概況
      • 財務（取決於數據的可用性）
      • 產品摘要
      • 近期發展情況
    • Alkem Laboratories Ltd.
    • Bayer AG
    • Cipla Ltd
    • Haleon plc
    • Infirst Healthcare Inc.
    • Pfizer Inc.
    • Prestige Consumer Healthcare Inc.
    • Reckitt Benckiser Group PLC,
    • WellSpring Pharmaceutical Corporation

第九章：研究過程

  • 研究過程
    • 資料探勘
    • 分析
    • 市場評估
    • 驗證
    • 出版
  • 研究屬性
  • 研究假設

Global Antacids Market is valued approximately USD XXX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2023-2030. Antacid is a sort of medicine that aids to reduce stomach acid and alleviates symptoms associated to excess acid. These over-the-counter medications have sodium bicarbonate, calcium, magnesium, or aluminum as active ingredients. They function by combining with stomach acid to create neutral chemicals that can lessen the acidity of the stomach contents. Antacids can therefore be used to treat symptoms including indigestion, heartburn, and acid reflux. Antacids are frequently used to treat symptoms brought on by excessive stomach acid. They aid in balancing the acid that is responsible for the burning in the chest or stomach. The key factor driving the market growth is rising prevalence of acid reflux and GERD, easy availability of OTC antacids, and rise in the demand for antacids among geriatric population that anticipated to support the market growth during forecast period.

Moreover, the rising geriatric population is one of the factors contributing to the growth of the antacids market. As people age, they are more prone to developing gastrointestinal problems such as acid reflux, heartburn, and gastroesophageal reflux disease (GERD). These conditions can cause discomfort and pain in the chest and throat and can also lead to other health complications. Thus, the rising geriatric population is anticipated to support the market growth. According to The World Bank, in 2015, the number of people aged 65 and above in India was 74.61 million and the number reached 95.75 million in 2021. Also, according to the same source, in 2016, the 22% of total population ages 65 and above in Italy and the number is reached 24% in 2021. As a result, the rising geriatric population in the region is anticipated to create a lucrative demand for the market. Additionally, rapidly changing lifestyle of global population is anticipated to create the lucrative opportunity for the market during forecast period. However, the growing number of alternatives in the market for antacids may stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Antacids Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the presence of key market players, availability of well-developed healthcare infrastructure, increase in incidences of heart burn cases, and easy availability of over-the-counter medication in this region. Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as rising geriatric population, growing presence of pharmaceutical companies, increase in healthcare expenditure and rise in awareness among people about heart burn are expected to drive market growth.

Major market players included in this report are:

  • Abbott Laboratories
  • Alkem Laboratories Ltd.
  • Bayer AG
  • Cipla Ltd
  • Haleon plc
  • Infirst Healthcare Inc.
  • Pfizer Inc.
  • Prestige Consumer Healthcare Inc.
  • Reckitt Benckiser Group PLC,
  • WellSpring Pharmaceutical Corporation

Recent Developments in the Market:

  • In June 2022, Zydus Lifesciences received final approval from the United States Food and Drug Administration (FDA) to market Famotidine tablets in the strengths of 20 mg and 40 mg. Famotidine is a histamine H2 receptor blocker. It works by reducing the amount of acid in the stomach.

Global Antacids Market Report Scope:

  • Historical Data: - 2020 - 2021
  • Base Year for Estimation: - 2022
  • Forecast period: - 2023-2030
  • Report Coverage: - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: - Formulation Type, Distribution Channel, Region
  • Regional Scope: - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope: - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Formulation Type:

  • Tablet
  • Powder
  • Others

By Distribution Channel:

  • Hospital Pharmacies
  • E-Commerce
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. Antacids Market, by Region, 2020-2030 (USD Billion)
    • 1.2.2. Antacids Market, by Formulation Type, 2020-2030 (USD Billion)
    • 1.2.3. Antacids Market, by Distribution Channel, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Antacids Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Antacids Market Dynamics

  • 3.1. Antacids Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Rising prevalence of acid reflux and GERD
      • 3.1.1.2. Easy availability of OTC antacids
      • 3.1.1.3. Rise in the demand for antacids among geriatric population
    • 3.1.2. Market Challenges
      • 3.1.2.1. Availability of substitute
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rapidly changing lifestyle of global population

Chapter 4. Global Antacids Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Antacids Market, by Formulation Type

  • 5.1. Market Snapshot
  • 5.2. Global Antacids Market by Formulation Type, Performance - Potential Analysis
  • 5.3. Global Antacids Market Estimates & Forecasts by Formulation Type 2020-2030 (USD Billion)
  • 5.4. Antacids Market, Sub Segment Analysis
    • 5.4.1. Tablet
    • 5.4.2. Powder
    • 5.4.3. Others

Chapter 6. Global Antacids Market, by Distribution Channel

  • 6.1. Market Snapshot
  • 6.2. Global Antacids Market by Distribution Channel, Performance - Potential Analysis
  • 6.3. Global Antacids Market Estimates & Forecasts by Distribution Channel 2020-2030 (USD Billion)
  • 6.4. Antacids Market, Sub Segment Analysis
    • 6.4.1. Hospital Pharmacies
    • 6.4.2. E-Commerce
    • 6.4.3. Others

Chapter 7. Global Antacids Market, Regional Analysis

  • 7.1. Top Leading Countries
  • 7.2. Top Emerging Countries
  • 7.3. Antacids Market, Regional Market Snapshot
  • 7.4. North America Antacids Market
    • 7.4.1. U.S. Antacids Market
      • 7.4.1.1. Formulation Type breakdown estimates & forecasts, 2020-2030
      • 7.4.1.2. Distribution Channel breakdown estimates & forecasts, 2020-2030
    • 7.4.2. Canada Antacids Market
  • 7.5. Europe Antacids Market Snapshot
    • 7.5.1. U.K. Antacids Market
    • 7.5.2. Germany Antacids Market
    • 7.5.3. France Antacids Market
    • 7.5.4. Spain Antacids Market
    • 7.5.5. Italy Antacids Market
    • 7.5.6. Rest of Europe Antacids Market
  • 7.6. Asia-Pacific Antacids Market Snapshot
    • 7.6.1. China Antacids Market
    • 7.6.2. India Antacids Market
    • 7.6.3. Japan Antacids Market
    • 7.6.4. Australia Antacids Market
    • 7.6.5. South Korea Antacids Market
    • 7.6.6. Rest of Asia Pacific Antacids Market
  • 7.7. Latin America Antacids Market Snapshot
    • 7.7.1. Brazil Antacids Market
    • 7.7.2. Mexico Antacids Market
  • 7.8. Middle East & Africa Antacids Market
    • 7.8.1. Saudi Arabia Antacids Market
    • 7.8.2. South Africa Antacids Market
    • 7.8.3. Rest of Middle East & Africa Antacids Market

Chapter 8. Competitive Intelligence

  • 8.1. Key Company SWOT Analysis
    • 8.1.1. Company 1
    • 8.1.2. Company 2
    • 8.1.3. Company 3
  • 8.2. Top Market Strategies
  • 8.3. Company Profiles
    • 8.3.1. Abbott Laboratories
      • 8.3.1.1. Key Information
      • 8.3.1.2. Overview
      • 8.3.1.3. Financial (Subject to Data Availability)
      • 8.3.1.4. Product Summary
      • 8.3.1.5. Recent Developments
    • 8.3.2. Alkem Laboratories Ltd.
    • 8.3.3. Bayer AG
    • 8.3.4. Cipla Ltd
    • 8.3.5. Haleon plc
    • 8.3.6. Infirst Healthcare Inc.
    • 8.3.7. Pfizer Inc.
    • 8.3.8. Prestige Consumer Healthcare Inc.
    • 8.3.9. Reckitt Benckiser Group PLC,
    • 8.3.10. WellSpring Pharmaceutical Corporation

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes
  • 9.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Antacids Market, report scope
  • TABLE 2. Global Antacids Market estimates & forecasts by Region 2020-2030 (USD Billion)
  • TABLE 3. Global Antacids Market estimates & forecasts by Formulation Type 2020-2030 (USD Billion)
  • TABLE 4. Global Antacids Market estimates & forecasts by Distribution Channel 2020-2030 (USD Billion)
  • TABLE 5. Global Antacids Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 6. Global Antacids Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 7. Global Antacids Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 8. Global Antacids Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 9. Global Antacids Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 10. Global Antacids Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 11. Global Antacids Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 12. Global Antacids Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 13. Global Antacids Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 14. Global Antacids Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 15. U.S. Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 16. U.S. Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 17. U.S. Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 18. Canada Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 19. Canada Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 20. Canada Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 21. UK Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 22. UK Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 23. UK Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 24. Germany Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 25. Germany Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 26. Germany Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 27. France Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 28. France Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 29. France Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 30. Italy Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 31. Italy Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 32. Italy Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 33. Spain Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 34. Spain Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 35. Spain Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 36. RoE Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 37. RoE Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 38. RoE Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 39. China Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 40. China Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 41. China Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 42. India Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 43. India Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 44. India Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 45. Japan Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 46. Japan Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 47. Japan Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 48. South Korea Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 49. South Korea Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 50. South Korea Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 51. Australia Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 52. Australia Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 53. Australia Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 54. RoAPAC Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 55. RoAPAC Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 56. RoAPAC Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 57. Brazil Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 58. Brazil Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 59. Brazil Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 60. Mexico Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 61. Mexico Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 62. Mexico Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 63. RoLA Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 64. RoLA Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 65. RoLA Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 66. Saudi Arabia Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 67. South Africa Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 68. RoMEA Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 69. List of secondary sources, used in the study of global Antacids Market
  • TABLE 70. List of primary sources, used in the study of global Antacids Market
  • TABLE 71. Years considered for the study
  • TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Antacids Market, research methodology
  • FIG 2. Global Antacids Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Antacids Market, key trends 2022
  • FIG 5. Global Antacids Market, growth prospects 2023-2030
  • FIG 6. Global Antacids Market, porters 5 force model
  • FIG 7. Global Antacids Market, pest analysis
  • FIG 8. Global Antacids Market, value chain analysis
  • FIG 9. Global Antacids Market by segment, 2020 & 2030 (USD Billion)
  • FIG 10. Global Antacids Market by segment, 2020 & 2030 (USD Billion)
  • FIG 11. Global Antacids Market by segment, 2020 & 2030 (USD Billion)
  • FIG 12. Global Antacids Market by segment, 2020 & 2030 (USD Billion)
  • FIG 13. Global Antacids Market by segment, 2020 & 2030 (USD Billion)
  • FIG 14. Global Antacids Market, regional snapshot 2020 & 2030
  • FIG 15. North America Antacids Market 2020 & 2030 (USD Billion)
  • FIG 16. Europe Antacids Market 2020 & 2030 (USD Billion)
  • FIG 17. Asia pacific Antacids Market 2020 & 2030 (USD Billion)
  • FIG 18. Latin America Antacids Market 2020 & 2030 (USD Billion)
  • FIG 19. Middle East & Africa Antacids Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable